









Markets
/
Stocks
/
nasdaq-tmo
/

Thermo Fisher Scientific Inc

TMO



View Detailed Chart

575.910USD

+3.630+0.63%

Close 12/15, 16:00（ET）Quotes delayed by 15 min

216.37BMarket Cap

33.23P/E TTM



Thermo Fisher Scientific Inc

575.910

+3.630+0.63%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Intraday

30m

Today

+0.63%

5 Days

+1.36%

1 Month

-0.48%

6 Months

+42.99%

Year to Date

+10.70%

1 Year

+9.30%

View Detailed Chart

TradingKey Stock Score of Thermo Fisher Scientific Inc

Currency: USD Updated: 2025-12-12

Key Insights

Thermo Fisher Scientific Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 24/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 626.78.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Thermo Fisher Scientific Inc's Score

Industry at a Glance

Industry Ranking

24 / 208

Overall Ranking

90 / 4592

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Analyst Rating

Based on 28 analysts

Buy

Current Rating

626.776

Target Price

+10.31%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Thermo Fisher Scientific Inc Highlights

StrengthsRisks

Thermo Fisher Scientific Inc. is engaged in accelerating life sciences research, solving complex analytical challenges, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. It also provides purification and filtration technologies.

Industry Leader

The company's revenue leads the industry, with the latest annual revenue totaling USD 42.88B.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 9.41%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 9.41%.

Fairly Valued

The company’s latest PE is 33.02, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 344.96M shares, decreasing 2.69% quarter-over-quarter.

Held by Mairs and Power

Star Investor Mairs and Power holds 6.32K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.04.

Thermo Fisher Scientific Inc News

Thermo Fisher Scientific To Acquire Solventum’S Purification And Filtration Business

Feb 25 (Reuters) - Thermo Fisher Scientific Inc TMO.N:THERMO FISHER SCIENTIFIC TO ACQUIRE SOLVENTUM’S PURIFICATION AND FILTRATION BUSINESSTHERMO FISHER SCIENTIFIC INC - TO ACQUIRE SOLVENTUM'S PURIFICATION & FILTRATION BUSINESS FOR $4.1 BILLIONTHERMO FISHER SCIENTIFIC INC - TRANSACTION EXPECT...

ReutersTue, Feb 25

Thermo Fisher Scientific Inc reports results for the quarter ended December 31 - Earnings Summary

Thermo Fisher Scientific Inc TMO.N reported quarterly adjusted earnings of $6.10 per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $5.67. The mean expectation of twenty five analysts for the quarter was for earnings of $5.94...

ReutersThu, Jan 30